Display Settings:

Format

Send to:

Choose Destination

    J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1532-72.

    Psychopharmacological treatment for very young children: contexts and guidelines.

    Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, Luby JL, Owens J, Scahill LD, Scheeringa MS, Stafford B, Wise B, Zeanah CH.

    Bradley Hasbro Research Center, Providence, RI 02903, USA. mgleason@lifespan.org

    Systematic research and practice guidelines addressing preschool psychopharmacological treatment in very young children are limited, despite evidence of increasing clinical use of medications in this population. The Preschool Psychopharmacology Working Group (PPWG) was developed to review existing literature relevant to preschool psychopharmacology treatment and to develop treatment recommendations to guide clinicians considering psychopharmacological treatment in very young children. This article reviews the developmental considerations related to preschool psychopharmacological treatment, presents current evidence bases for specific disorders in early childhood, and describes the recommended algorithms for medication use. The purpose of this effort is to promote responsible treatment of young children, recognizing that this will sometimes involve the use of medications.

    PMID: 18030077 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Dexmethylphenidate (Focalin®)

      Dexmethylphenidate is used as part of a treatment program to control symptoms of Attention Deficit Hyperactivity Disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other peop...

    • Methylphenidate (Concerta®, Metadate®, Methylin®, ...)

      Methylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people ...

    • Risperidone (Risperdal®, Risperdal® M-TAB®)

      Risperidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and teenagers 13 years of ...

    • » See all 4 drug reports ...